Reference number
Coordinator Apiconisis AB
Funding from Vinnova SEK 300 000
Project duration April 2012 - October 2012
Status Completed

Purpose and goal

Apiconisis, a spin-off company from KTH and KI, is a life science company that offers advanced fluorescence-based services to develop 21st century pharmacology. Although we are a young company, the underlying technology and medical mechanism concept were to a large extent initiated by researchers at the Karolinska already in the 70 - and 80 s. So there is a long tradition and expertise in the Stockholm area in our field. Apiconisis is a product of this tradition.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2012-00568

Page statistics